Analyst Reco. RXO, Inc.

Equities

RXO

US74982T1034

Market Closed - Nyse Other stock markets 16:00:02 2024-05-14 EDT			5-day change	1st Jan Change
21.17 ^USD	+0.91%		+2.17%	-8.99%

05-02	RXO Swings to Q1 Loss as Revenue Falls; Shares Rise	MT
05-02	Transcript : RXO, Inc., Q1 2024 Earnings Call, May 02, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Susquehanna Raises RXO Price Target to $16 From $15, Maintains Negative Rating	03-25	MT
Oppenheimer Trims RXO Price Target to $22 From $23, Maintains Outperform Rating	02-13	MT
UBS Adjusts RXO Price Target to $22 From $20, Maintains Neutral Rating	02-09	MT
Susquehanna Adjusts Price Target on RXO to $15 From $18, Maintains Negative Rating	02-09	MT
BofA Securities Adjusts Price Target on RXO to $25 From $21, Maintains Buy Rating	01-16	MT
Stifel Adjusts RXO's Price Target to $22 From $20, Maintains Hold Rating	01-10	MT
Vertical Research Downgrades RXO to Hold From Buy, Trims Price Target to $23 From $24	01-10	MT
Oppenheimer Adjusts RXO Price Target to $23 From $20, Maintains Outperform Rating	12-14	MT
UBS Adjusts RXO Price Target to $20 From $21, Maintains Neutral Rating	11-08	MT
Oppenheimer Adjusts RXO Price Target to $20 From $24, Maintains Outperform Rating	11-08	MT
JPMorgan Downgrades RXO to Underweight From Neutral, Trims Price Target to $16 From $17	23-10-11	MT
Morgan Stanley Adjusts RXO's Price Target to $18 From $20, Keeps Equalweight Rating	23-10-02	MT
Susquehanna Downgrades RXO to Negative From Neutral, Adjusts Price Target to $14 From $19	23-08-31	MT
Goldman Sachs Adjusts Price Target on RXO to $21 From $20, Maintains Neutral Rating	23-08-04	MT
UBS Adjusts RXO Price Target to $21 From $23, Maintains Neutral Rating	23-08-03	MT
Stephens Adjusts Price Target on RXO to $19 From $21, Maintains Equal-Weight Rating	23-08-03	MT
Goldman Sachs Adjusts Price Target on RXO to $20 From $21, Maintains Neutral Rating	23-07-12	MT
Wolfe Research Downgrades RXO to Underperform From Peer Perform, Sets $18 Price Target	23-07-12	MT
Susquehanna Initiates RXO at Neutral With $20 Price Target	23-06-09	MT
Barclays Initiates RXO at Overweight Rating With Price Target $27	23-05-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. RXO, Inc.

Equities

RXO

US74982T1034

Analyst Reco.

Filters